Impact of Modern Art Therapy on Patients' Anxiety and Pain During the Waiting Time in an Emergency Department

December 1, 2022 updated by: Olivier Hugli

The primary objective of this study is to investigate whether, during a waiting period in an emergency department, the patient's participation in a modern art therapy session decreases the patient's level of anxiety and pain.

As a secondary objective, this study aims to explore whether participation in a modern art therapy session is perceived positively by the patient. This objective will be assessed by both patient self-report and art therapist heteroreport.

In this work, the investigators will therefore seek to demonstrate the potential positive impact of modern art therapy conducted during times of waiting for examination or results.

Study Overview

Status

Completed

Detailed Description

After reviewing the patients' medical records in the emergency department, and verifying the inclusion and exclusion criteria with the caregivers in charge of the case, the investigators will introduce themselves to the patients and offer them to participate in the study. The investigators will explain to the patients that their emergency department experience involves waiting time and that they are eligible for this study aimed at improving the well-being of emergency department patients during waiting time. Patients will be informed that the study aims to investigate the distracting effect of a modern art therapy session. If the patients ask about the modalities of the session, the investigators will answer that it will consist of an artistic production in accordance with their tastes and abilities, defined with the art therapist or a discussion with the research nurse about art therapy and its place in an emergency department and that they will be randomly assigned to one of the two groups.

At this stage, only oral consent will be obtained. After verifying that all inclusion criteria are met, that none of the exclusion criteria are applicable, and obtaining oral consent, each patient will be randomized 1:1 between the two study arms using the randomization module in the RedCap® software. The investigator in charge of data collection will collect some additional data in a standardized way by following the case report form.

The art therapist will then be able to intervene with the patient if the latter is part of the group participating in an art therapy session. A five- to ten-minute interview with the patient will allow the art therapist to get to know the patient and to learn more about his or her tastes and any contraindications the patient may have to certain techniques. This interview will begin with a discussion of the patient's general condition, both physical (pain, injury) and mental (mood), with the goal of assessing preserved and mobilizable abilities as well as affected and non-mobilizable mechanisms. The patient's tastes (artistic or other) will also be briefly questioned. Since the art-therapeutic intervention that will be proposed seeks to generate pleasant feelings, it will be important to rely on the patient's tastes. It is the patient's tastes and choices that will guide the decision of the dominant artistic elements, in order to maximize the pleasure taken in the activity and the distracting effect of the proposal. At the end of the interview, modern art therapy will be presented to the patient and several artistic activities will be proposed:

  • Origami: paper folding activity requiring good fine motor skills, possible if the patient can fully use his/her hands. Requires a flat surface to put the paper on.
  • Drawing: with dry techniques that will be disinfected after each use. It could be a drawing of invention, a comic strip to complete, an extension of a photo by a drawing...
  • Writing: with markers or pens to allow for quick drying and avoid smearing. Creative writing games working on the imagination can be proposed.

All paper elements intended to be contemplated (models or works of art) will be wrapped in plastic to allow disinfection between each use.

Once the activity has been chosen, the patient will have 15 to 20 minutes to carry it out, accompanied by the art therapist according to his/her needs (explanations, gestural and technical support, partial or total realization by the art therapist under the patient's orders...). During the activity, verbal exchanges will continue. After the 15 to 20 minutes of the session, 5 minutes will be devoted to the patient's self-evaluation of the past moment, of his level of anxiety, of the intensity of his pain and of his feelings in relation to his passage in the Emergency Department and the art therapy session. The question will then be raised as to what will happen to the production, which will either be discarded or given to the patient to take with him/her.

The materials used for this study are common plastic arts materials (pencils, markers, paper) that are non-toxic and non-dirty. Reproductions of artworks in the form of postcards may also be shown to the patients.

For the control group without art therapy, the patient will be left in the usual waiting conditions for 20 to 30 minutes. After this waiting time, the patient will be asked to self-assess his or her level of anxiety, pain intensity and feelings about his or her visit to the emergency department.

Once all the data has been collected, a complete information sheet and a consent form will be given to the patient. Additional explanations can be given upon request. Patients will have a minimum of 15 minutes to sign the consent form.

Study Type

Interventional

Enrollment (Actual)

146

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Vaud
      • Lausanne, Vaud, Switzerland, 1011
        • Centre Hospitalier Universitaire Vaudois (CHUV)

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients 18 years of age or older
  • Patient whose management requires waiting for a procedure, an examination or results
  • Patient whose pain is evaluated at least 3/10 by a VAS on arrival in the emergency room.

Exclusion Criteria:

  • Clinically unstable patients (i.e., admitted to the intensive care unit or deemed unstable by the physician or nurse responsible for the patient)
  • Patient incapable of judgement or with whom it is difficult to communicate
  • Altered mental status (e.g. cognitive impairment, mental retardation, acute confusional state, acute psychosis)
  • Intoxication
  • Alcohol abuse
  • Patient unable to communicate in French at a level sufficient to give informed consent and answer questions related to their anxiety and pain
  • Patient unable to understand the use of VAS scales
  • Patient incarcerated
  • Patient transferred from another hospital
  • Patient who has participated in this study at a previous visit
  • Patient with chronic pain

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention
After 5-10 minute interview with the patient to define his or her tastes and contraindications to certain techniques. The patient will have 15 to 20 minutes to carry out an artistic activity, accompanied by the art therapist according to his/her needs. During the activity, verbal exchanges will continue. After the session, 5 minutes will be devoted to the patient's self-evaluation of the past moment, of his level of anxiety, of the intensity of his pain and of his feelings in relation to his passage in the Emergency Department and the art therapy session.

The intervention will begin with a 5-10 minute interview with the patient to define his or her tastes and contraindications to certain techniques. Since the art-therapeutic intervention that will be proposed seeks to generate pleasant feelings, it will be important to rely on the patient's tastes. At the end of the interview, modern art therapy will be presented to the patient and several artistic activities will be proposed (origami, drawing, creative writing).

Once the activity has been chosen, the patient will have 15 to 20 minutes to carry it out, accompanied by the art therapist according to his/her needs. During the activity, verbal exchanges will continue. After the 15 to 20 minutes of the session, 5 minutes will be devoted to the patient's self-evaluation of the past moment, of his level of anxiety, of the intensity of his pain and of his feelings in relation to his passage in the Emergency Department and the art therapy session.

No Intervention: Control
The questionnaires and VAS will be offered to the control group at the beginning of the wait, then after 30 minutes of waiting under usual conditions.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Anxiety self-assessment
Time Frame: Up to 4 hours (from admission in the departement to end of session)
The primary outcomes of this study will be patients' self-assessment of their anxiety status using a visual analog scale and a validated questionnaire This measurement will be taken before and after an art therapy session during their waiting time in the emergency department.
Up to 4 hours (from admission in the departement to end of session)
Anxiety self-assessment
Time Frame: Up to 4 hours (from admission in the departement to end of session)
The primary outcomes of this study will be patients' self-assessment of their anxiety status using the State-Trait Anxiety Inventory. This measurement will be taken before and after an art therapy session during their waiting time in the emergency department.
Up to 4 hours (from admission in the departement to end of session)
Pain self- assessment
Time Frame: Up to 4 hours (from admission in the departement to end of session)
The primary outcomes of this study will be patients' self-assessment of their pain intensity using a visual analog scale. This measurement will be taken before and after an art therapy session during their waiting time in the emergency department.
Up to 4 hours (from admission in the departement to end of session)
Anxiety assessment
Time Frame: 20 minutes (during the session)
The art therapist will also assess the patient's anxiety during the session using items that allow the recording of observable phenomena on a scale from 1 to 5, 1 beeing the worse outcome, 5 the best.
20 minutes (during the session)
Pain assessment
Time Frame: 20 minutes (during the session)
The art therapist will also assess the patient's pain during the session using items that allow the recording of observable phenomena on a scale from 1 to 5, 1 beeing the worse outcome, 5 the best.
20 minutes (during the session)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pleasure self-assessment
Time Frame: 1 minute (end of session)
The secondary results of this study will be the patient's self-evaluation by visual analog scale of the pleasure felt during the activity. 1 will be the worse outcome, 10 the best.
1 minute (end of session)
Feeling towards the passage in the emergency department
Time Frame: 1 minute (end of session)
Questions will be asked to the patient regarding how he feels about his passage in the emergency department. The possible answers will be "poor", "fair", "good", "excellent". They will be converted in numbers from 1 to 4, 4 (excellent) being the best outcome.
1 minute (end of session)
Quality of realization self-assessment
Time Frame: 1 minute (end of session)
The secondary results of this study will be the patient's self-evaluation by visual analog scale of the quality of its realization.1 will be the worse outcome, 10 the best.
1 minute (end of session)
Aesthetic pleasure self-assessment
Time Frame: 1 min (end of session)
The secondary results of this study will be the patient's self-evaluation by visual analog scale of the aesthetic pleasure felt in front of their realization. 1 will be the worse outcome, 10 the best.
1 min (end of session)
Pleasure towards the activity self-self assessment
Time Frame: 1 min (end of session)
The secondary results of this study will be the patient's self-evaluation by visual analog scale of the pleasure expressed towards the activity. 1 will be the worse outcome, 10 the best.
1 min (end of session)
Engagement of the patient in the activity assessment
Time Frame: 20 minutes (during the session)
The engagement of the patient in the activity during the session will also be evaluated by the art-therapist using items that allow the recording of observable phenomena on a scale from 1 to 5, 1 beeing the worse outcome, 5 the best.
20 minutes (during the session)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2021

Primary Completion (Actual)

November 30, 2021

Study Completion (Actual)

November 30, 2021

Study Registration Dates

First Submitted

July 19, 2021

First Submitted That Met QC Criteria

August 2, 2021

First Posted (Actual)

August 9, 2021

Study Record Updates

Last Update Posted (Actual)

December 5, 2022

Last Update Submitted That Met QC Criteria

December 1, 2022

Last Verified

December 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pain, Acute

Clinical Trials on Art-therapy in the emergency department

3
Subscribe